- call +1-201-465-4211
- email sales@mrinsights.biz
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment.
Scope of the Report:
This report focuses on the Antibody Drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The worldwide market for Antibody Drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Adcetris
Kadcyla
Market Segment by Applications, can be divided into
Breast Cancer
Lymphoma
There are 15 Chapters to deeply display the global Antibody Drug Conjugates market.
Chapter 1, to describe Antibody Drug Conjugates Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antibody Drug Conjugates, with sales, revenue, and price of Antibody Drug Conjugates, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibody Drug Conjugates, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antibody Drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antibody Drug Conjugates sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antibody Drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Lymphoma
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffman-La Roche
2.1.1 Business Overview
2.1.2 Antibody Drug Conjugates Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Antibody Drug Conjugates Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda Pharmaceutical
2.3.1 Business Overview
2.3.2 Antibody Drug Conjugates Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Antibody Drug Conjugates Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Seattle Genetics
2.5.1 Business Overview
2.5.2 Antibody Drug Conjugates Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Genentech
2.6.1 Business Overview
2.6.2 Antibody Drug Conjugates Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Immunogen
2.7.1 Business Overview
2.7.2 Antibody Drug Conjugates Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Progenics Pharmaceuticals
2.8.1 Business Overview
2.8.2 Antibody Drug Conjugates Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer Healthcare Pharmaceuticals
2.9.1 Business Overview
2.9.2 Antibody Drug Conjugates Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antibody Drug Conjugates Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antibody Drug Conjugates Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antibody Drug Conjugates Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody Drug Conjugates Manufacturer Market Share in 2017
3.3.2 Top 6 Antibody Drug Conjugates Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antibody Drug Conjugates Market Analysis by Regions
4.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Regions
4.1.1 Global Antibody Drug Conjugates Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Regions (2013-2018)
4.2 North America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.3 Europe Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.5 South America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5 North America Antibody Drug Conjugates by Countries
5.1 North America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
5.1.1 North America Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
5.2 United States Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5.3 Canada Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5.4 Mexico Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6 Europe Antibody Drug Conjugates by Countries
6.1 Europe Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
6.1.1 Europe Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.3 UK Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.4 France Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.5 Russia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.6 Italy Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antibody Drug Conjugates by Countries
7.1 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
7.2 China Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.3 Japan Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.4 Korea Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.5 India Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8 South America Antibody Drug Conjugates by Countries
8.1 South America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
8.1.1 South America Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8.3 Argentina Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8.4 Colombia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antibody Drug Conjugates by Countries
9.1 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.3 UAE Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.4 Egypt Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.5 Nigeria Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.6 South Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
10 Global Antibody Drug Conjugates Market Segment by Type
10.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antibody Drug Conjugates Sales and Market Share by Type (2013-2018)
10.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2013-2018)
10.2 Adcetris Sales Growth and Price
10.2.1 Global Adcetris Sales Growth (2013-2018)
10.2.2 Global Adcetris Price (2013-2018)
10.3 Kadcyla Sales Growth and Price
10.3.1 Global Kadcyla Sales Growth (2013-2018)
10.3.2 Global Kadcyla Price (2013-2018)
11 Global Antibody Drug Conjugates Market Segment by Application
11.1 Global Antibody Drug Conjugates Sales Market Share by Application (2013-2018)
11.2 Breast Cancer Sales Growth (2013-2018)
11.3 Lymphoma Sales Growth (2013-2018)
12 Antibody Drug Conjugates Market Forecast (2018-2023)
12.1 Global Antibody Drug Conjugates Sales, Revenue and Growth Rate (2018-2023)
12.2 Antibody Drug Conjugates Market Forecast by Regions (2018-2023)
12.2.1 North America Antibody Drug Conjugates Market Forecast (2018-2023)
12.2.2 Europe Antibody Drug Conjugates Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antibody Drug Conjugates Market Forecast (2018-2023)
12.2.4 South America Antibody Drug Conjugates Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antibody Drug Conjugates Market Forecast (2018-2023)
12.3 Antibody Drug Conjugates Market Forecast by Type (2018-2023)
12.3.1 Global Antibody Drug Conjugates Sales Forecast by Type (2018-2023)
12.3.2 Global Antibody Drug Conjugates Market Share Forecast by Type (2018-2023)
12.4 Antibody Drug Conjugates Market Forecast by Application (2018-2023)
12.4.1 Global Antibody Drug Conjugates Sales Forecast by Application (2018-2023)
12.4.2 Global Antibody Drug Conjugates Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antibody Drug Conjugates Picture
Table Product Specifications of Antibody Drug Conjugates
Figure Global Sales Market Share of Antibody Drug Conjugates by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
